DIONNE LUCAS: Open Payments
NPI 1912056003 · WALDORF, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$355 in 16 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $99 · 2025 $355
Food & beverage: $355
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 4 | $86 |
| Novo Nordisk Inc | 2 | $48 |
| PFIZER INC. | 2 | $47 |
| AstraZeneca Pharmaceuticals LP | 2 | $41 |
| Tactile Systems Technology Inc | 1 | $31 |
| Neurocrine BioSciences, Inc. | 1 | $24 |
| Lilly USA, LLC | 1 | $23 |
| Globus Medical, Inc. | 1 | $21 |
| Novartis Pharmaceuticals Corporation | 1 | $19 |
| Exact Sciences Corporation | 1 | $16 |
Products named: REPATHA, Rybelsus, PREVNAR 20, AIRSUPRA, Flexitouch Plus, INGREZZA, MOUNJARO, Senza.
Industry payments across MD — which companies pay providers there.
